To find promising hits we offer diverse screening platforms combined with chemoinformatics and medicinal chemistry supported by artificial intelligence.
- A priori selection
Selection of molecules based on publications, virtual screening and medicinal chemistry knowledge.
- Fragment Screening
The NovA-Frag library of 1000 fragments can be screened on different biophysical platforms such as NMR or native MS.
- Covalent screening
Native-MS screening using client or commercial covalent libraries.
- DNA Encoded Libraries (NovA-DEL)
Massive screening in parallel of customized general or focused libraries.